Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma

Table 3

Different combinations of estrogen/progesterone expression in metaplastic carcinoma.

ER/PR expression	Values
ER positive, PR positive, n (%)	24 (17.1)
ER positive, PR negative, n (%)	18 (12.9)
ER negative, PR positive, n (%)	4 (2.9)
ER negative, PR negative, n (%)	94 (67.1)

ER: estrogen receptor; PR: progesterone receptor.